Navigation Links
Gerresheimer: Record Year in 2007 and Positive Outlook for 2008
Date:2/26/2008


DUSSELDORF, Germany, February 26 /PRNewswire-FirstCall/ --

- Sales in 2007 Increased by 48.1% to EUR957.7m

- Operating Results (Adjusted EBITDA) up by 48.1% at EUR181.6m

- Proposed Dividend: EUR0.40 Per Share - CEO Dr. Axel Herberg: "For the Financial Year 2008 we Expect Further Sales Growth, With an Improved Margin."

Gerresheimer AG has finished the financial year 2007 with record figures in terms of sales and results. The company increased its sales by 48.1% to EUR957.7m (2006: EUR646.7m). Excluding acquisition and exchange-rate effects, Gerresheimer reports above-average sales growth of 8.4%. Operating results (Adjusted EBITDA) rose by 48.1% from EUR122.6m in the prior year to EUR181.6m. The company's operating strength is shown by the Adjusted EBITDA margin of 19.0%.

The debt level before the IPO and the one-off costs of the IPO are reflected in consolidated results of EUR0.8m (2006: EUR-25.0m). In the fourth quarter, however, consolidated results already totalled EUR13.9m, reaching a level which was no longer depressed by IPO costs and for the first time reflected the company's low level of debt. The adjusted consolidated results improved strongly during the financial year to EUR44.3m (2006: EUR8.7m).

"We have achieved all the targets we set ourselves for 2007 and in many cases exceeded them. For our company we look back over a very successful financial year", says Dr. Axel Herberg, CEO of Gerresheimer AG. Against the background of this brilliant business development, the Management Board and the Supervisory Board will propose to the Shareholders' Meeting that a dividend is already distributed for the financial year of the IPO, which is to amount to EUR0.40 per share.

Continuation of globalisation strategy

The strong growth of Gerresheimer AG is attributable on the one hand to above-average organic growth and on the other hand to acquisitions. The Wilden Group, which was acquired at the sta
'/>"/>

SOURCE Gerresheimer AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. CIGNA Medical Group Selects Allscripts for Electronic Health Record
2. Eklin Medical Reports Record Revenues for 2007
3. Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients
4. GeoPharma Announces Record Revenues in Third Quarter Results
5. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
6. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
7. BioSpace Career Fair in San Diego Draws Record Number of Bioscience Candidates
8. Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31, 2007
9. Bioponic Phytoceuticals Announces Record Sales Increase of 40% for the Month of January
10. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
11. 2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , MARKHAM, ON, Nov. 25 /PRNewswire/ - Cyto...ldt, PhD to its Board of Directors. Dr. Moldt will...ative on the Company,s Board. The number of Board ...e are very pleased to welcome Peter Moldt to the b...ience and guidance as Cytochroma continues to make...
(Date:11/24/2009)... This release is available in German . , Wh...ion cards: RFID tags (Radio Frequency Identificati...ay life. They make it possible to label objects or...equency. The appropriate scanner can read and proc...can be affixed to goods under production condition...
(Date:11/24/2009)..., , SANTA CRUZ, Calif., Nov. 24 /PRNewsw...ned Bio Career Center, the nation,s leading online...ssionals. ,, Northwestern and Columbia Universi...her major life science training Institutions. ,...y for post-graduates in the life sciences. While t...
(Date:11/24/2009)... Health care employment g...ns the only one to show consistent growth during t...hospitals remain in trouble, and health systems ar...personnel, instead of just administrators. , ...ealth care employment continued growing in October...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...AMIR, Israel, Jan. 14 Shamir,Optical Industry Ltd...of,innovative products and technology to the progr...t its board of directors had declared a dividend,d...ion (approximately NIS,15.1 million based on the J...or approximately US$ 0.243 (approximately NIS 0.91...
...nd HAIKOU, China, Jan. 14 /Xinhua-PRNewswire-First...a,) (OTC Bulletin Board: CPHI),which develops, man...aceutical products in China, today announced that ...itiate a proactive and targeted investor,relations...I, and their,collective team, will be advising the...
...an. 14 Today, The Woodbridge Group announced,the ...industry,s highest,levels of "Green" Polyurethane ...e strategy, BioFoam, a patented technology, substi...ing of polyurethane products. This,earth-friendly ...,applications includes; seat cushions, seat fabric...
Other Biology Technology:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 2China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 3Woodbridge Offers the Broadest Range of BioFoam(TM) 'Green' Polyurethane Automotive Interior Applications 2
(Date:11/26/2009)...cus Aureus ) and other drug-resistant bacteria cou...totype devices have been developed to offer safe, ..., Two prototype devices have been developed: one...hands and feet) in hospitals and public spaces whe...to shoot bacteria-killing agents into infested chr...
(Date:11/25/2009)...ath Research Laboratory in the University of Haifa...stigious Johnson & Johnson Focused Funding grant f...damage in Parkinson,s disease. The award, which is...ovation and excellence in science, was announced i...h at an event at the Hyatt Regency Hotel in New Je...
(Date:11/24/2009)...ribed by traditional healers in Brazil to treat a ...to fever and flu. , Now for the first time, resea...cientifically prove the pain relieving properties ...mint. , Testing this ancient South American herb ... was able to show that when prepared as a ,tea, t...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Celebrate June Is Dairy Month Beginning With Breakfast 48128 1Celebrate June Is Dairy Month Beginning With Breakfast 48128 2Windows XP Vista and Windows 7 Compatible Remote Control 4 0 Beta Released by IntelliAdmin LLC 48124 1Windows XP Vista and Windows 7 Compatible Remote Control 4 0 Beta Released by IntelliAdmin LLC 48124 2Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 1Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 2Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 3Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 4Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 5Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 6Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 7Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 8
... variations ensure that no two people are exactly .... Now, researchers have the tools and the knowled... cancer therapies, enabling them to create more ef...ized medicine. At the 2007 Annual Meeting of the A...rs present new biomarkers ?and techniques for dete...
...by" hysteria of the 1980s was greatly exaggerated,... disabling cognitive impairments -- attention defi.... , A recent study by investigators at the Vander...ent may help explain the long-term behavioral and ...osure to cocaine. In a recent issue of the Journal...
...e that nanoparticles, engineered materials about a...d lead to cancer, according to research presented ...tion for Cancer Research. , Nanoparticles are smal... yet they are large enough to cause trouble by int...t the University of Massachusetts say. Such nanop...
Other Biology News:Genes and biomarkers that allow doctors to choose the right therapy for the right patient 2Genes and biomarkers that allow doctors to choose the right therapy for the right patient 3Genes and biomarkers that allow doctors to choose the right therapy for the right patient 4Genes and biomarkers that allow doctors to choose the right therapy for the right patient 5Genes and biomarkers that allow doctors to choose the right therapy for the right patient 6Prenatal cocaine's lasting cellular effects 2Prenatal cocaine's lasting cellular effects 3Cancer tip -- Nanoparticles can damage DNA, increase cancer risk 2
...apidCycler is the first instrument engineered to m...d by thousands of research centers worldwide. It u... are ideally suited for high-speed temperature cyc...rface-area-to-volume ratio. ,By combining glass c...
Freund's Incomplete Adjuvant, Modified from Calbiochem
...RY Array LNA microarray slides for microRNA expre...ides incorporate Exiqons unique Locked Nucleic Aci...ty and excellent mismatch discrimination for short... on less than 1 g total RNA (no need for microRNA ...
Tyrode's Salts solution from Sigma-Aldrich
Biology Products: